ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Adipose Tissue Macrophages as Initiators of Exacerbated Periodontitis in Estrogen-Deficient Environments via the Amplifier Extracellular Vesicles.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- Gut Microbiota Has the Potential to Improve Sarcopenic Obesity in Menopausal Women by Regulating Estrogen.International journal of women's health · 2026Review
- Associations between periodontal disease-induced immune cell activation and energy metabolism.Frontiers in immunology · 2026Review
- Adipose Tissue Macrophages as Initiators of Exacerbated Periodontitis in Estrogen-Deficient Environments via the Amplifier Extracellular Vesicles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Immunocyte-derived extracellular vesicles in osteoimmunology: mechanisms, disease contexts, and translational prospects.Frontiers in immunology · 2025Review
- Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Periodontitis in menopausal women tends to exacerbate, potentially resulting in tooth loss and increased risk of systemic diseases. The prior research demonstrates that pro-inflammatory changes in macrophages under estrogen deficiency exacerbate periodontitis. However, the primary environmental factors contributing to the alteration of monocyte-macrophages remain unknown. Recent studies, including animal models and clinical trials, have found a correlation between accumulation of visceral adipose tissue (VAT) and periodontitis progression in postmenopausal women. In estrogen-deficient mice, macrophages in VAT show a pro-inflammatory state. Removing VAT alleviates periodontitis in OVX mice. DNA methylation sequencing shows increased methylation in macrophages, especially Jazf1 hypermethylation, inhibiting its expression and promoting inflammation. Subsequently, small extracellular vesicles (sEVs) derived from pro-inflammatory macrophages further intensify M1-like polarization in resting macrophages, carrying inflammatory microRNAs like miR-30e-5p. Overall, this study proposes a novel perspective: periodontal pathogens act as initial triggers for inflammation, while chronic systemic inflammation, worsened by estrogen deficiency, is the main factor that exacerbates periodontitis. Pro-inflammatory macrophages in VAT release sEVs, which activate resting macrophages into a pro-inflammatory state upon encountering periodontal pathogens, resulting in persistent inflammation. Addressing the root causes of this dysregulation can lead to new therapeutic strategies for periodontitis and systemic inflammatory conditions, particularly in postmenopausal women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.